Table 4.
Patient characteristics
| Variable | Control group (n = 73) |
Liver transplant recipients (n = 12) |
p value |
|---|---|---|---|
| Gender, n (% female) | 8 (11) | 7 (58) | 0.001 |
| Age, mean (SD) | 66.6 ± 10.1 | 56.7 ± 10.7 | 0.005 |
| Body surface area (m2) | 1.96 ± 0.2 | 1.92 ± 0.2 | 0.509 |
| Body mass index (kg/m2) | 26.4 ± 3.4 | 21.9 ± 1.1 | <0.001 |
| Hypertension, n (%) | 40 (54.8) | 1 (8.3) | 0.004 |
| Diabetes, n (%) | 3 (4.1) | 1 (8.3) | 0.462 |
| Beta-adrenergic blocker, n (%) | 58 (79.5) | 7 (58.3) | 0.143 |
| ACE inhibitor, n (%) | 37 (50.7) | 2 (16.7) | 0.033 |
| Calcium antagonist, n (%) | 12 (16.4) | 0 (0) | 0.201 |
| Diuretics, n (%) | 3 (4.1) | 8 (66.7) | <0.001 |
| - Aldosterone antagonists, n (%) | 6 (50%) | ||
| Preoperative serum creatinine (μmol/l) | 82.7 ± 11.4 | 70.8 ± 13.9 | 0.001 |
| Preoperative estimated GFR (mL/min) | 84.5 ± 14.5 | 86.9 ± 19.8 | 0.690 |
| Preoperative measured GFR (mL/min) | - | 85.5 ± 18.7 | - |
Values are means ± SD, n = number of patients (%). Estimated GFR; using MDRD (Modification of Diet in Renal Disease) formula
ACE inhibitor angiotensin-converting enzyme inhibitor, GFR glomerular filtration rate